Search for in this collection

Subscribe to this collection to receive daily e-mail notification of new additions

Preview	Issue Date	Title	Author(s)
	26-Aug-2026	Performance of digital single operator cholangioscopy biliary sampling vs ERCP brushings and cold biopsies in indeterminate biliary lesions: an Australian experience.	Reynauld B.; Swan M.
	27-Aug-2026	Sustained efficacy of zanubrutinib vs bendamustine+rituximab: 6-year follow-up in the phase 3 SEQUOIA study.	Munir T.; Tam C.S.; Robak T.; Brown J.R.; Kahl B.; Ghia P.; Opat S.S.; Walker P.A.; Lasica M.; Flinn I.W.; Shen J.; Kuptsova-Clarkson N.; Lefebure M.; Hirata J.; Jurczak W.; Shadman M.
	27-Aug-2026	Bomedemstat for polycythemia vera resistant or intolerant to cytoreductive therapy: Phase 2 Shorespan-004 study.	Rein L.; Livings A.; Frewin R.; Innes A.; Mahdi A.; Rinaldi C.; Curto-Garcia N.; Vaughn J.; Shatzel J.; Yeh P.; Flynn J.; Jutzi J.S.; Marinello P.; Leahy M.F.
	27-Aug-2026	Glofitamab plus gemcitabine/oxaliplatin in relapsed/refractory diffuse large B-cell lymphoma: Phase III STARGLO trial 3-year follow-up.	Townsend W.; Abramson J.; Ku M.; Fox C.; Huang H.-Q.; Zhang H.; Yoon D.H.; Kim W.-S.; Abdulhaq H.; Herbaux C.; Zaucha J.; Chang H.; Mulvihill E.; Kesavan M.; Kallemeijn M.; Ta R.; Choeurng V.; Bottos A.; Lundberg L.; Gregory G.
	28-Aug-2026	Disease-causing tlr7 variants reveal molecular and cellular mechanisms of human systemic autoimmunity.	Vinuesa C.; Grenov A.; Maurice D.; Gantier M.; Rahman A.
	1-Sep-2026	Patient perspectives on pain: a cross-sectional study of patient views on pain management after uterine artery embolisation.	Subramaniam S.; Profeta R.; Duncan R.; Zia A.; Hunt L.; Quach K.; Li R.; Lukies M.; Goh G.; Clements W.
	2-Sep-2026	Short Corpus Callosum on Fetal Magnetic Resonance Imaging (MRI): Clinical Outcomes and Genetic Associations.	Klapczynski C.; Rolnik D.L. ; Goergen S.K.
	26-Aug-2026	Performance of digital single operator cholangioscopy biliary sampling vs ERCP brushings and cold biopsies in indeterminate biliary lesions: an Australian experience.	Reynauld B.; Swan M.
	27-Aug-2026	Sustained efficacy of zanubrutinib vs bendamustine+rituximab: 6-year follow-up in the phase 3 SEQUOIA study.	Munir T.; Tam C.S.; Robak T.; Brown J.R.; Kahl B.; Ghia P.; Opat S.S.; Walker P.A.; Lasica M.; Flinn I.W.; Shen J.; Kuptsova-Clarkson N.; Lefebure M.; Hirata J.; Jurczak W.; Shadman M.
	27-Aug-2026	Glofitamab plus gemcitabine/oxaliplatin in relapsed/refractory diffuse large B-cell lymphoma: Phase III STARGLO trial 3-year follow-up.	Townsend W.; Abramson J.; Ku M.; Fox C.; Huang H.-Q.; Zhang H.; Yoon D.H.; Kim W.-S.; Abdulhaq H.; Herbaux C.; Zaucha J.; Chang H.; Mulvihill E.; Kesavan M.; Kallemeijn M.; Ta R.; Choeurng V.; Bottos A.; Lundberg L.; Gregory G.
	28-Aug-2026	Disease-causing tlr7 variants reveal molecular and cellular mechanisms of human systemic autoimmunity.	Vinuesa C.; Grenov A.; Maurice D.; Gantier M.; Rahman A.
	1-Sep-2026	Patient perspectives on pain: a cross-sectional study of patient views on pain management after uterine artery embolisation.	Subramaniam S.; Profeta R.; Duncan R.; Zia A.; Hunt L.; Quach K.; Li R.; Lukies M.; Goh G.; Clements W.
	2-Sep-2026	Short Corpus Callosum on Fetal Magnetic Resonance Imaging (MRI): Clinical Outcomes and Genetic Associations.	Klapczynski C.; Rolnik D.L. ; Goergen S.K.
	19-Aug- 18	Staff Perspectives on Mealtime Practices in Bed-Based Services	Williams M. ; Antolasic W.; Beswick E.; Campbell C.; Hsieh S.; Luongo J.; Martin A.; Yuke I.; Stewart A. ; Silvers M.
	13-Aug-2025	Development of CSANZ and ACRA Position Statement on Quality Use of Telehealth in Cardiovascular Care.	Cartledge S.; Rawstorn J.; Astley C.; Bourne C.; Bardsley K.; Bart N.; Driscoll A.; Hall T.; Hendriks J.; Scott A.; Straiton N.; Thomas E.; Inglis S.
	13-Aug-2025	Patient Outcomes Associated With Cardiac Rehabilitation in Victoria, Australia: A Linked Data Analysis.	Cartledge S.; Lucas M.; Dinh D.; Brennan A.; Gauci S.; O'Neil A.; Thomas E.; Gallagher R.; Redfern J.; Reid C.; Lefkovits J.; Driscoll A.; Stub D.
	28-Jul-2026	EVALUATION OF PET-CT METRICS AND PHARMACOKINETICS IN ADULTS RECEIVING TISLELIZUMAB FOR RELAPSED/REFRACTORY CLASSICAL HODGKIN LYMPHOMA: ANCILLARY ANALYSES OF LYSA PHASE 2 TIRHOL STUDY BGB-A317-210.	Ghesquieres H.; Bouabdallah K.; Kanoun S.; Andre M.; Quittet P.; Borel C.; Bastard A.S.; Gilbertson M. ; Le Bras F.; Thieblemont C.; Moisdon B.D.; Touati M.; Feugier P.; Renaud L.; Morineau N.; Gastinne T.; Chaillol I.; Ramchandren R.; Shah H.; Modi D.; Allewelt H.; Fustier P.; Liu X.; Zhang J.; Delarue R.; Morschhauser F.; Rossi C.
	28-Jul-2026	IRF4 AND SERBP1 EXPRESSION ARE ASSOCIATED WITH POOR RESPONSES TO GUADECITABINE (SGI-110) THERAPY IN PERIPHERAL T CELL LYMPHOMA.	Behrouzfar K.; Abeyakoon C.; Waltham M.; Dorwal P.; Maher B.; Sabouri-Thompson Z.; Scull K.; Brasacchio D.; Gasiorowski R.; Shortt J. ; Yeh P.
	28-Jul-2026	COMBINATION TREATMENT WITH NOVEL BCL2 INHIBITOR SONROTOCLAX (BGB-11417) AND ZANUBRUTINIB IN PATIENTS WITH RELAPSED/REFRACTORY MANTLE CELL LYMPHOMA (R/R MCL): RESULTS FROM A PHASE 1/1B STUDY.	Soumerai J.; Tam C.S.; Lasica M.; Hoffmann M.; Sanz R.G.; Schetelig J.; Munir T.; Weinkove R.; Browett P.; Barca E.G.; Mayer L.M.; Bernardelli A.; Hou J.-Z.; Cordoba R.; Wu B.; Man G.; Fang Y.; Patel S.; Vezan R.; Opat S.
	28-Jul-2026	TOTAL METABOLIC TUMOR VOLUME AND CIRCULATING TUMOR DNA AS EARLY PROGNOSTIC FACTORS IN RELAPSED/REFRACTORY DIFFUSE LARGE B-CELL LYMPHOMA: RESULTS FROM THE PHASE 3 STARGLO TRIAL.	Townsend W.; Belousov A.; Abramson J.S.; Ku M.; Huang H.; Fox C.P.; Zhang H.-L.; Yoon D.H.; Kim W.; Ghesquieres H.; Herbaux C.; Zhang Q.-Y.; Abdulhaq H.; Jemaa S.; Mulvihill E.; Kallemeijn M.J.; Kesavan M.; Lundberg L.; Bottos A.; Gregory G.P.